FREE Daily Stock Alerts From Stock-PR.com
Medtronic, Inc. (NYSE:MDT) announced that the U.S. Food & Drug Administration (FDA) has approved its ConsultaÂ® and Syncra™ cardiac resynchronization therapy-pacemaker (CRT-P) systems. Consulta is the first CRT-P that includes Medtronic‘s exclusive OptiVolÂ® Fluid Status Monitoring, which identifies patients at risk for worsening heart failure before symptoms develop.3-9 Additionally, both Consulta and Syncra are the first CRT-Ps that include Leadless ECG Waveform, which together with the Medtronic CareLinkÂ® Network device data monitoring system, offer the possibility of remote follow-up in heart failure patients implanted with these devices. Shipments of Consulta and Syncra will begin immediately.
Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. Medtronic, Inc. was founded in 1949 and is headquartered in Minneapolis, Minnesota.
Biomass, a renewable energy source, is biological material from living, or recently living organisms, such as wood, waste, (hydrogen) gas, and alcohol fuels.
Example of Successful Wood-Waste-to-Energy Applications: Wood-Fired Cogeneration Provides Reliable Off-Grid Power for Maryland Correctional Facility
A Maryland Department of Corrections facility has cut its fuel costs by 63 percent by producing its own power using a wood-chip-fired cogeneration plant.
Read more at: http://stock-pr.com/?p=16451